Cargando…

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

BACKGROUND: S-1 is an oral fluoropyrimidine whose antitumor effects have been demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer, when administered as monotherapy or in combination chemotherapy. We conducted a randomized phase III study investigating the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143094/ https://www.ncbi.nlm.nih.gov/pubmed/24942277 http://dx.doi.org/10.1093/annonc/mdu232

Ejemplares similares

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial
por: Mochizuki, I, et al.
Publicado: (2012)

S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial
por: Watanabe, J., et al.
Publicado: (2021)

Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer
por: Kusumoto, Tetsuya, et al.
Publicado: (2018)

Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
por: Ishiguro, Megumi, et al.
Publicado: (2012)

A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
por: Oki, E., et al.
Publicado: (2016)

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer
por: Katakami, N, et al.
Publicado: (2018)

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11)
por: Sunakawa, Y., et al.
Publicado: (2022)

Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial
por: Kurokawa, Y, et al.
Publicado: (2016)

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer
por: Ishiguro, Megumi, et al.
Publicado: (2013)

Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis
por: Sugita, S, et al.
Publicado: (2008)

Intra- and Extra-Articular Deformity of Lower Limb: Tibial Condylar Valgus Osteotomy (TCVO) and Distal Tibial Oblique Osteotomy (DTOO) for Reconstruction of Joint Congruency
por: Watanabe, Y., et al.
Publicado: (2019)

The CREAM-III Calorimeter
por: Malinin, A, et al.
Publicado: (2007)

An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
por: Ichikawa, W, et al.
Publicado: (2015)

Data acquisition system of the CANGAROO-III telescope
por: Kubo, H, et al.
Publicado: (2001)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation
por: Fujisaka, Y, et al.
Publicado: (2011)

Development of light guides for the camera of CANGAROO-III telescope
por: Kajino, F, et al.
Publicado: (2001)

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer
por: Okusaka, Takuji, et al.
Publicado: (2017)

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
por: Shiroiwa, T., et al.
Publicado: (2016)

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
por: Yamada, Y, et al.
Publicado: (2018)

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
por: Hotta, K., et al.
Publicado: (2022)

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study
por: Tomita, Naohiro, et al.
Publicado: (2019)

Ammonia and lactate blood levels on hospital arrival predict neurological outcome in patients with out-of-hospital cardiac arrest
por: Shinozaki, K, et al.
Publicado: (2011)

High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients
por: Itakura, M, et al.
Publicado: (2013)

Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
por: Yasui, H., et al.
Publicado: (2023)

Ferroelectrics and related substances: revised, updated and extended edition of volumes III/3 and III/9
por: Hellwege, K-H, et al.
Publicado: (1981)

Ferroelectrics and related substances: revised, updated and extended edition of volumes III/3 and III/9
por: Hellwege, K-H, et al.
Publicado: (1982)

Surgical management and outcome analysis of stage III pediatric empyema thoracis
por: Menon, Prema, et al.
Publicado: (2010)

3-Weekly Paclitaxel-Carboplatin With Radical Radiation for Stage III NSCLC – An Option During COVID-19 Pandemic
por: Wong, H.C.Y., et al.
Publicado: (2021)

Factors Affecting Positive Peritoneal Lavage Cytology in Patients with Stage II and III Colorectal Cancer with R0 Resection: A Multi-institutional, Prospective Study
por: Sato, Harunobu, et al.
Publicado: (2021)

CC2D1B Coordinates ESCRT-III Activity during the Mitotic Reformation of the Nuclear Envelope
por: Ventimiglia, Leandro N., et al.
Publicado: (2018)

Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502
por: Sadahiro, S., et al.
Publicado: (2015)

As(iii) removal through catalytic oxidation and Fe(iii) precipitation
por: Oshima, Kazumasa, et al.
Publicado: (2022)

Nomograms predicting survival and recurrence in colonic cancer in the era of complete mesocolic excision
por: Kanemitsu, Y., et al.
Publicado: (2019)

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
por: Kaira, K, et al.
Publicado: (2008)

Novel lanthanide(III) 4-methylbenzoylhydrazide complexes as precursors for lanthanide oxide nanophotocatalysts
por: El-Enein, S. A. Abou, et al.
Publicado: (2019)

Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial
por: Kim, J., et al.
Publicado: (2017)

A Pilot Study of Social Competence Assessment Using Interaction Rating Scale Advanced
por: Anme, T., et al.
Publicado: (2011)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer
por: Negoro, S, et al.
Publicado: (2003)

Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro
por: Mochizuki, M., et al.
Publicado: (1994)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_t383us2k4bcr040onsias8khm1